These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9282925)

  • 1. Mianserin-induced down-regulation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y.
    Newton RA; Elliott JM
    J Neurochem; 1997 Sep; 69(3):1031-8. PubMed ID: 9282925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative desensitization of the human 5-HT2A and 5-HT2C receptors expressed in the human neuroblastoma cell line SH-SY5Y.
    Briddon SJ; Leslie RA; Elliott JM
    Br J Pharmacol; 1998 Oct; 125(4):727-34. PubMed ID: 9831908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating mutations of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Egan C; Teitler M
    J Neurochem; 1997 Sep; 69(3):1138-44. PubMed ID: 9282936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.
    Barker EL; Westphal RS; Schmidt D; Sanders-Bush E
    J Biol Chem; 1994 Apr; 269(16):11687-90. PubMed ID: 7909313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
    Herrick-Davis K; Grinde E; Niswender CM
    J Neurochem; 1999 Oct; 73(4):1711-7. PubMed ID: 10501219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
    Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
    Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of serotonin 5-HT2C receptors by chronic ligand exposure.
    Devlin MG; Smith NJ; Ryan OM; Guida E; Sexton PM; Christopoulos A
    Eur J Pharmacol; 2004 Sep; 498(1-3):59-69. PubMed ID: 15363976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA; Schutz LJ
    J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors.
    Akiyoshi J; Isogawa K; Yamada K; Nagayama H; Fujii I
    Biol Psychiatry; 1996 Jun; 39(12):1000-8. PubMed ID: 8780834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional reconstitution in situ of 5-hydroxytryptamine2c (5HT2c) receptors with alphaq and inverse agonism of 5HT2c receptor antagonists.
    Hartman JL; Northup JK
    J Biol Chem; 1996 Sep; 271(37):22591-7. PubMed ID: 8798428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
    Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
    Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
    Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Grinde E; Gauthier C; Teitler M
    Ann N Y Acad Sci; 1998 Dec; 861():140-5. PubMed ID: 9928251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple 5-HT receptors in the guinea-pig superior cervical ganglion.
    Watkins CJ; Newberry NR
    Br J Pharmacol; 1996 Jan; 117(1):21-8. PubMed ID: 8825338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
    López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
    Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous serotonin-2A and -2C receptors in Balb/c-3T3 cells revealed in serotonin-free medium: desensitization and down-regulation by serotonin.
    Saucier C; Morris SJ; Albert PR
    Biochem Pharmacol; 1998 Nov; 56(10):1347-57. PubMed ID: 9825734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
    Berg KA; Stout BD; Maayani S; Clarke WP
    J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.